2025-08-21 01:00Financial Performance Highlights - VONB increased by 14% to $2,838 million[11], driven by broad-based growth across 13 markets[49] - OPAT per share increased by 12%[11], reflecting higher earnings and ROE[41] - UFSG per share increased by 10% to $3,569 million[11] - Interim dividend per share increased by 10% to 49.00 HK cents[47] - $3.7 billion was returned to shareholders[13] Key Growth Drivers - AIA Hong Kong's VONB grew by 24% to $1,063 million[15], supported by agency and bancassurance channels[15] - AIA China's VONB reached $743 million in 1H25[17], with a VONB margin exceeding 65%[17] - ASEAN combined VONB increased by 20%[22], driven by traditional protection products[22] - Tata AIA Life's VONB increased by 38%[25], positioning it as a top 3 private life insurer in India[25] Strategic Initiatives - The company is deploying Gen AI at scale to accelerate growth across core platforms[38] - The company is focused on integrated healthcare strategy to make healthcare more accessible, affordable, and effective[35] - The company is building a differentiated and sustainable bancassurance model in China, focusing on HNW customers[104] Capital Management - The company maintains a strong shareholder capital ratio of 219% after returning $3.7 billion to shareholders[47, 82] - The company has a disciplined capital deployment strategy, with $22 billion returned since 2022[81] - The company targets a payout ratio of 75% of annual net free surplus generation[75]